[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”3.22.3″][et_pb_row admin_label=”row” _builder_version=”3.22.3″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.0.47″][et_pb_text _builder_version=”3.24″]On June 11, 2019, Forchronic, S.L., a company participated by Canaan Research & Investment, presented its investment proposal at the Foro Capital Pymes held in the Palacio de la Bolsa of Madrid.

Foro Capital Pymes (FCP) is an entity that organizes meetings with national and international investors, with the mission of presenting to the investment community the opportunity to invest in the capital of already consolidated companies. FCP selected the Forchronic proposal after analyzing its viability and studying the profitability that would be the capital investment in it.

Forchronic was presented to an audience of some 50 potential investors, Venture Capital, Industrial and Family Office profiles, R & D funds, among others, and presented the project that develops, based on a new generation of precision nutraceuticals with therapeutic activity , as well as the potential products of the company’s portfolio.

Mr. Guillermo Reglero Rada, President of Forchronic and Professor of Food Sciences of the Universidad Autónoma de Madrid, had the opportunity to present confidentially the proposal of the company to the investing public and participate in the networking, creating a first contact between our company and various interested investors.[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]

Leave a Reply

Your email address will not be published.